A randomized, double-blind, placebo-controlled pilot study to assess the ability of rifaximin to prevent recurrent diarrhoea in patients with Clostridium difficile infection.
Garey KW; Ghantoji SS; Shah DN; Habib M; Arora V; Jiang ZD; DuPont HL; The Journal Of Antimicrobial Chemotherapy, 2011, vol. 66, issue 12, p 2850, ISSN 14602091. ISBN 14602091.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef